Jonathan I. Epstein

5.1k total citations · 1 hit paper
49 papers, 4.0k citations indexed

About

Jonathan I. Epstein is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Jonathan I. Epstein has authored 49 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 27 papers in Rheumatology and 12 papers in Surgery. Recurrent topics in Jonathan I. Epstein's work include Prostate Cancer Diagnosis and Treatment (30 papers), Urologic and reproductive health conditions (27 papers) and Prostate Cancer Treatment and Research (26 papers). Jonathan I. Epstein is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (30 papers), Urologic and reproductive health conditions (27 papers) and Prostate Cancer Treatment and Research (26 papers). Jonathan I. Epstein collaborates with scholars based in United States, Australia and India. Jonathan I. Epstein's co-authors include Alan W. Partin, Patrick C. Walsh, Marné J. Carmichael, Theresa Y. Chan, Sheldon Bastacky, Patrick C. Walsh, Paul B. Gaudin, Juan Rosaí, Hillel Kahane and Octavio A. Armas and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Jonathan I. Epstein

49 papers receiving 3.8k citations

Hit Papers

Pathologic and Clinical Findings to Predict Tumor Extent ... 1994 2026 2004 2015 1994 400 800 1.2k

Peers

Jonathan I. Epstein
R. Joseph Babaian United States
V. Ravery France
Donald F. Gleason United States
Alwyn M. Reuther United States
Mark K. Buyyounouski United States
Joan Sweet Canada
Lakshmi P. Kunju United States
R. Joseph Babaian United States
Jonathan I. Epstein
Citations per year, relative to Jonathan I. Epstein Jonathan I. Epstein (= 1×) peers R. Joseph Babaian

Countries citing papers authored by Jonathan I. Epstein

Since Specialization
Citations

This map shows the geographic impact of Jonathan I. Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan I. Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan I. Epstein more than expected).

Fields of papers citing papers by Jonathan I. Epstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan I. Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan I. Epstein. The network helps show where Jonathan I. Epstein may publish in the future.

Co-authorship network of co-authors of Jonathan I. Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan I. Epstein. A scholar is included among the top collaborators of Jonathan I. Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan I. Epstein. Jonathan I. Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Somarelli, Jason A., Daneen Schaeffer, Matthew S. Marengo, et al.. (2016). Distinct routes to metastasis: plasticity-dependent and plasticity-independent pathways. Oncogene. 35(33). 4302–4311. 37 indexed citations
2.
Roberts, William W., Erik J. Bergstralh, Michael L. Blute, et al.. (2001). Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology. 57(6). 1033–1037. 69 indexed citations
3.
Halachmi, Sarel, Angelo M. De Marzo, Nan‐Haw Chow, et al.. (2000). Genetic Alterations in Urinary Bladder Carcinosarcoma: Evidence of a Common Clonal Origin. European Urology. 37(3). 350–357. 51 indexed citations
4.
5.
Fritsch, Michael K., Jonathan I. Epstein, Elizabeth J. Perlman, John Watts, & Pedram Argani. (2000). Molecularly confirmed primary prostatic synovial sarcoma. Human Pathology. 31(2). 246–250. 15 indexed citations
6.
Baisden, Blaire L., Hillel Kahane, & Jonathan I. Epstein. (1999). Perineural Invasion, Mucinous Fibroplasia, and Glomerulations. The American Journal of Surgical Pathology. 23(8). 918–918. 41 indexed citations
7.
Kadkol, Shrihari S., Jonathan R. Brody, Jonathan I. Epstein, Francis P. Kuhajda, & Gary R. Pasternack. (1998). Novel nuclear phosphoprotein pp32 is highly expressed in intermediate- and high-grade prostate cancer. The Prostate. 34(3). 231–237. 45 indexed citations
8.
Wills, Marcia L., et al.. (1998). Partial Atrophy in Prostate Needle Cores. The American Journal of Surgical Pathology. 22(4). 440–445. 42 indexed citations
9.
Cadeddu, Jeffrey A., Alan W. Partin, Jonathan I. Epstein, & Patrick C. Walsh. (1997). Stage D1 (T1-3, N1-3, M0) Prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy. Urology. 50(2). 251–255. 76 indexed citations
10.
Weinstein, Michael H. & Jonathan I. Epstein. (1997). Telepathology diagnosis of prostate needle biopsies. Human Pathology. 28(1). 22–29. 69 indexed citations
11.
Silver, Richard I., Alan W. Partin, Jonathan I. Epstein, et al.. (1997). Prostate-specific antigen in men born with bladder exstrophy. Urology. 49(2). 253–256. 5 indexed citations
12.
Veltri, Robert W., Michael Craig Miller, Alan W. Partin, Donald S. Coffey, & Jonathan I. Epstein. (1996). Ability to predict biochemical progression using gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei. Urology. 48(5). 685–691. 45 indexed citations
13.
Epstein, Jonathan I., Marné J. Carmichael, & Alan W. Partin. (1995). OA-519 (fatty acid synthase) as an independent predictor of pathologic stage in adenocarcinoma of the prostate. Urology. 45(1). 81–86. 182 indexed citations
14.
Bastacky, Sheldon, Susan A. Silver, & Jonathan I. Epstein. (1994). Composite cytological smears of pelvic lymph nodes at the time of radical prostatectomy to identify nodal metastases. Human Pathology. 25(12). 1352–1359. 3 indexed citations
15.
Epstein, Jonathan I., et al.. (1992). Evaluation of Radical Prostatectomy Specimens. The American Journal of Surgical Pathology. 16(4). 315–324. 140 indexed citations
16.
Epstein, Jonathan I. & Octavio A. Armas. (1992). Atypical Basal Cell Hyperplasia of the Prostate. The American Journal of Surgical Pathology. 16(12). 1205–1214. 69 indexed citations
17.
Hamper, Ulrike M., Sameer A. Sheth, P C Walsh, Patrice M. Holtz, & Jonathan I. Epstein. (1991). Capsular transgression of prostatic carcinoma: evaluation with transrectal US with pathologic correlation.. Radiology. 178(3). 791–795. 33 indexed citations
18.
Sheth, Sheila, Ulrike M. Hamper, P C Walsh, Patrice M. Holtz, & Jonathan I. Epstein. (1991). Stage A adenocarcinoma of the prostate: transrectal US and sonographic-pathologic correlation.. Radiology. 179(1). 35–39. 20 indexed citations
19.
Tempany, Clare M., et al.. (1991). Invasion of the neurovascular bundle by prostate cancer: evaluation with MR imaging.. Radiology. 181(1). 107–112. 49 indexed citations
20.
Fishman, Elliot K., et al.. (1990). Uterine perforation simulating urachal carcinoma: CT diagnosis.. American Journal of Roentgenology. 154(4). 741–743. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026